U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07623265) titled 'Improving the Use of Immunotherapy to Treat Liver Cancer' on Feb. 06, 2025.
Brief Summary: This project targets patients with a form of primary liver cancer, specifically "hepatocellular carcinoma". This disease often develops in the context of a chronically diseased liver, caused by viral infections, excessive alcohol consumption, or fatty liver. Primarily due to the rise of the latter risk factor, liver cancer is one of the few cancer types whose incidence continues to increase globally, year after year. As a result, liver cancer has become the third most common cause of cancer-related deaths worldwide. There exists a significant c...